Stay updated on Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial
Sign up to get notified when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.

Latest updates to the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page
- Check4 days agoChange DetectedFooter text updated to Revision: v3.6.6; deleted older references to 'Multiple myeloma', 'related topics:', 'MedlinePlus Genetics', and the previous revision tag 'Revision: v3.6.5'.SummaryDifference0.2%

- Check11 days agoChange DetectedMultiple myeloma is now listed as a topic on the page, and a Related topics entry for MedlinePlus Genetics has been added.SummaryDifference0.1%

- Check18 days agoChange Detected- Removed the 'Multiple myeloma' label and the 'MedlinePlus Genetics' link from the related topics area. This reduces disease-specific context and removes a genetics resource for users.SummaryDifference0.1%

- Check25 days agoChange DetectedMultiple myeloma and MedlinePlus Genetics were added as related topics, expanding the page's linked resources. The site revision was updated to v3.6.5 from v3.6.4.SummaryDifference0.2%

- Check40 days agoChange DetectedThe revision tag on the page was updated from v3.6.3 to v3.6.4. This appears to be a backend or build update and does not change study details or user-facing content.SummaryDifference0.0%

- Check47 days agoChange DetectedRemoved the 'Multiple myeloma' label, the 'related topics:' header, and the 'MedlinePlus Genetics' entry from the Related Topics section.SummaryDifference0.1%

Stay in the know with updates to Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.